INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
33
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$3,816
1,363 sh
Jun 12, 2026
Page 213 of 532
← PrevNext →
Jun 29, 2026
traded Jun 12, 2026
+17d
SEC Form 4

Evidence

33
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$794K
40.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

33
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,400
240.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

33
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale
SELL$21.64M
700.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

29
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$298K
14.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

29
MB
Miller Paul BlaineSee Remarks
GOGrocery Outlet Holding Corp.
Open-market purchase
BUY$48K
5,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

28
EG
Elsztain Alejandro GustavoDirector
LNDBrasilAgro - Brazilian Agricultural Real Estate Co
Open-market purchase
BUY$52K
14.5K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

28
MM
Mindlin Marcos MarceloDirector, 10% Owner
PAMPampa Energy Inc.
Open-market purchase
BUY$969K
287.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

28
EG
Elsztain Alejandro GustavoDirector
LNDBrasilAgro - Brazilian Agricultural Real Estate Co
Open-market purchase
BUY$51K
14.5K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

25
HY
Huang YingDirector, Chief Executive Officer
LEGNLegend Biotech Corp
Open-market sale
SELL$82K
5,566 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

25
BJ
Bitterman Robert JDirector, Chairman, Pres. & CEO
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$9,900
10.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

24
GE
Giles Bryan ECHIEF FINANCIAL OFFICER
AVOMission Produce, Inc.
Open-market sale
SELL$61K
5,000 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

23
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$387K
7,878 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

20
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$250K
2,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$106K
331 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$67K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
BS
Bobulsky SusanChief Commercial Officer, MRD
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$103K
5,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$70K
211 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$104K
18.1K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$186K
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

15
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$298K
11.4K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$33K
100 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

14
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$66K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$634K
11.5K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$7,826
1,373 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
DA
Doudna Jennifer ADirector
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
2,673 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$63K
500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

8
AH
Anderson David HugoDirector
NWNNorthwest Natural Holding Co
Open-market sale · 10b5-1 plan
SELL$76K
1,500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$36K
110 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$49K
150 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$26K
79 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,200 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

4
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$167K
33.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

4
DS
Dhanasekaran SatishDirector, President and CEO
KEYSKeysight Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$183K
507 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

1
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$500
100 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

1
RN
Rosenberg NickExecutive Vice President
MCBMetropolitan Bank Holding Corp.
Open-market sale · 10b5-1 plan
SELL$26K
263 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

1
RN
Rosenberg NickExecutive Vice President
MCBMetropolitan Bank Holding Corp.
Open-market sale · 10b5-1 plan
SELL$9,005
90 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence